相关实验视频

Updated: May 22, 2025

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke

Published on: January 3, 2025

缺血性中风的细胞生物标志物:潜力和前景

Wendi Wang^1,2, Qing Han^1,2,3, Tianwei Wang^1,2

¹Department of Neurology, Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong 271000, China.

Analytical chemistry

|May 20, 2025

概括

细胞在缺血性中风 (IS) 期间显示了像MMP9这样的炎症标志物的增加. 抑制ASK1可以降低这些标记物,从而保持血脑屏障的完整性. PDGFRβ和MMP9显示出早期IS诊断的潜力.

科学领域:

神经科学是一个神经科学.
生物标志物发现发现
血管生物学血管生物学

背景情况:

缺血性中风 (IS) 具有显著的死亡风险.
早期诊断和IS的个性化治疗依赖于核心生物标志物的多重检测.
皮质细胞作为潜在的IS生物标志物的作用需要研究.

研究的目的:

探索皮细胞作为缺血性中风生物标志物的潜力.
调查ASK1信号传递在细胞周围细胞对缺血反应中的作用.
为IS生物标志物开发一种新的检测方法.

主要方法:

在体外缺血模型使用细胞周围细胞.
通过ASK1-shRNA转染来抑制ASK1的表达.
在患者血样本上进行ELISA测定.
开发一种光传感器,用于双生物标志物检测.

主要成果:

缺血在皮细胞中的炎症和亡因子 (例如,MMP9) 被上调.
抑制ASK1降低了炎症标志物,增强了细胞周围细胞的收缩和迁移,并保持了血脑屏障的完整性.
血中的PDGFRβ和MMP9度与NIHSS得分相关.
为PDGFRβ和MMP9检测开发了一种敏感且稳定的光传感器.

结论:

细胞在对缺血的反应中表现出显著的变化,表明它们作为IS生物标志物的潜力.
向皮细胞中的ASK1信号可能为IS提供治疗效益.
PDGFRβ和MMP9是早期IS诊断和预后预测的有希望的生物标志物,使用开发的光传感器技术进行预测.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...